The Agri-Cortex
Market Intelligence · Sourced Scoreboard

India×Europe

One place to compare the two smart-protein economies — every figure sourced, dated, and flagged for confidence, with the definitions that don't line up called out rather than hidden. Tap any row to see where the number comes from.

Reviewed monthly · last updated July 2026
High confidence — official / primary source Medium — reputable estimate Directional — definitions differ or synthesis
🇮🇳 INDIA
small base · rising · fast clock
$0.0B
alt-protein market, 2030 · from ~$0.8B (2023) · smart-protein segment surging
◇ Grand View · GFI India
×
🇪🇺 EUROPE
large · maturing · slow clock
import ↦ soya ↦
$0.0B
alt-protein market, 2030 · from ~$5.3B (2023), ~8% CAGR
â—‡ Grand View / Horizon
Each tank fills from its 2023 level (dashed) to 2030 — the rise is the growth; clock speed shows pace. Same metric & year: alt-protein market, 2030 · sources on the scoreboard.
Precision fermentation approvals
🇮🇳Case-by-case: yes
🇪🇺Zero
India cleared whey via its novel-food route; EU has approved none.
The edge each holds
🇮🇳Cost & feedstock
🇪🇺Science & strains
Low-capex manufacturing vs deep R&D and IP.
The Scoreboard

Metric by metric, side by side

The same measures for both regions. Where a like-for-like comparison isn't possible, the row is flagged directional and the mismatch explained on expand.

Metric
🇮🇳 India
🇪🇺 Europe

Cross-region figures are directional, not like-for-like: sources define "smart protein", "alt-protein" and "inputs" differently. Each cell carries its own source and date on expand.

India × Europe · Profile

Complementary strengths, at a glance

The scoreboard above compares the two economies row by row. This is the shape of it: Europe leads on market size, private capital and strain science; India on growth, manufacturing, policy, regulatory speed and feedstock. Hover a point for the read.

India Europe
Explore the full interactive comparison →

Profile scores are Agri-Cortex synthesis (directional, 0–100); the underlying figures are sourced on the scoreboard above and on the market-analysis page.

Regulatory Tracker · EFSA vs FSSAI

Who can actually sell what, where

The most decision-relevant — and fastest-moving — data in the field: approval status by product category in each jurisdiction. Tap a row for the dossier detail and source.

Product category
🇮🇳 India · FSSAI
🇪🇺 Europe · EFSA / EC
Approved / cleared In progress / case-by-case No approval yet

India clears novel proteins one product at a time under its "Non-Specified Food" route rather than category-wide rules; Europe authorises via the EU Novel Food Regulation after an EFSA safety opinion. Dates reflect the latest public milestone as of July 2026.

How this is built

Sourced, dated, and honest about the gaps

Every figure here is compiled from public sources — industry bodies (GFI, GFI India, GFI Europe), government and regulatory bodies (DBT/BioE3, FSSAI, EFSA, the European Commission), and market-research firms — with a source and date attached to each cell. Numbers are indicative and, across regions, directional rather than like-for-like: analysts define the market differently, so we show the mismatch instead of papering over it. Regulatory status changes fast; this page carries a review date and is maintained on a monthly cadence rather than published once.

Independent analysis, compiled from public sources. Not investment advice.

Sources: GFI · GFI India · GFI Europe · Circana · Grand View · Deloitte · McKinsey · DBT / BioE3 · FSSAI · EFSA · European Commission (DG AGRI) · MNRE / NPMCR · company & regulatory disclosures. Prepared by Dr. Nitika Mukhi · agricortex.in
◗ The Agri-Cortex brief

Read the shift before it’s obvious.

Sourced, dated intelligence on the India × Europe smart-protein economy — new briefings, tracker updates and the occasional field guide. No noise.

Independent analysis · not investment advice · unsubscribe anytime.